Sonja Ständer: New Therapies for Chronic Pruritus and Prurigo
Touch Medical Media coverage of data presented at EADV 2021:
touchIMMUNOLOGY had the great pleasure of speaking with Prof. Sonja Ständer (University Hospital Münster, Münster, Germany) about new treatments for chronic pruritus and prurigo.
Her presentation entitled ‘New treatments for chronic pruritus and prurigo’ was given at the EADV 30th Congress, 29 Sep – 2 Oct.
Disclosures: Prof. Sonja Ständer has acted as an investigator for Dermasence, Galderma, Kiniksa, Menlo, Trevi, Novartis, Sanofi and Vanda. She has also received consultancy/ advisory board/ speaker fees from Abbvie, Almirall, Beiersdorf, Bellus Health, Benevolent, Bionorica, Cara, Clexio, Escient, Galderma, Grünenthal, Kiniksa, Leo, Lilly, Menlo, Pfizer, Sanofi, Trevi, P.G. Unna Academy and Vifor.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Gina Furnival.
Filmed in coverage of the EADV’s 30th Congress, 29 Sep – 2 Oct 2021.
This content was developed by Touch Medical Media and is not affiliated with the European Academy of Dermatology & Venereology (EADV) or the congress.
